1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
656D2EF086639F79200258C3700453D05
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-effective-oncology-solid-tumors-medical-insights-management-tools-activities-training?opendocument
18
19opendocument
2018.97.14.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Effective Oncology (Solid Tumors) Medical Insights Management: Tools, Activities, and Training

ID: 5854


Features:

8 Info Graphics

47 Data Graphics

1170+ Metrics

2 Narratives


Pages/Slides: 64


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Effective Oncology (Solid Tumors) Medical Insights Management: Tools, Activities, and Training”

STUDY OVERVIEW

Staying ahead in the field of oncology, particularly solid tumors, requires more than just gathering insights—it demands the right tools, strategically coordinated activities, and ongoing training to ensure that valuable information translates into meaningful impact. Identifying the top approaches that truly enhance Medical Affairs effectiveness is key to optimizing performance in this space.

Best Practices, LLC conducted this benchmarking study to identify the most effective tools, activities, and training methodologies used by leading Medical Affairs teams in oncology (solid tumors). This study reveals best practices that drive insight dissemination, equipping organizations with the strategies needed to optimize performance and maximize scientific influence in the solid tumors segment.

Benchmark data is broken down into two different segments to provide deeper insights. Classifications reflect their approach and standing in oncology (solid tumors) medical insight generation: Insight Leaders (6 respondents) and Insight Majority (28 respondents).


KEY TOPICS

  • Oncology (Solid Tumors) Insights Gathering Activities
  • Coordination for Oncology (Solid Tumors) Insights Gathering
  • Training Techniques and Tools for Oncology (Solid Tumors) Insights Gathering

KEY METRICS

  • Highly effective team coordination tactics and tools within Medical Affairs – Total benchmark class, Insight Leaders, and Insight Majority
  • Effectiveness of listed tactics and tools used by the Oncology (Solid Tumors) Medical Affairs group to coordinate work, data, and analyses for stakeholders – Total benchmark class, Insight Leaders, and Insight Majority
  • Use of different tools for oncology (solid tumors) insight gathering in Medical Affairs; Integration of insights into a unified platform using different tools
  • Percentage of intelligence gathering work involving primary (field) research and secondary research in oncology (solid tumors) – Total benchmark class, Insight Leaders, and Insight Majority
  • Effectiveness and importance of primary and secondary data collection sources in oncology (solid tumors) – Total benchmark class, Insight Leaders, and Insight Majority
  • Frequency of usage of primary and secondary sources for collecting intelligence data within Oncology (Solid Tumors) Medical Affairs – Total benchmark class, Insight Leaders, and Insight Majority
  • Effectiveness of internal sources that support intelligence data collection in oncology (solid tumors) – Total benchmark class, Insight Leaders, and Insight Majority
  • Functions and groups used within Oncology (Solid Tumors) Medical Affairs organization to narrow the focus of the issue and discover information gaps – Total benchmark class, Insight Leaders, and Insight Majority
  • Internal limitations to receiving oncology (solid tumors) medical insights
  • Effectiveness of training techniques for insights data collection in oncology (solid tumors) – Total benchmark class, Insight Leaders, and Insight Majority

SAMPLE KEY FINDINGS

  • Primary and Secondary Data Sources: Look to expand the groups used to collect data used to generate insights. Internal sources require deeper training and secondary resources require deeper technology to make effective.

METHODOLOGY

Best Practices, LLC partnered with 34 executives from 23 top life sciences companies specializing in oncology (solid tumors) to uncover critical benchmarking insights. The study insights are mostly from directors and higher management executives, representing nearly 80% of the benchmark participants.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Communications; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical; Science


Companies Profiled:
Agios; Alkermes; ApotheCom; AstraZeneca; Bayer; Boehringer Ingelheim; Clovis Oncology; Daiichi Sankyo; Eisai; Eli Lilly and Company; Genentech; Ipsen; Janssen; Merck KGaA; Merck; Novartis; Roche; Sandoz; Sanofi Genzyme; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Teva Pharmaceuticals; Thermo Fisher Scientific

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.